Free tool

ORBIT bleeding risk calculator

Score bleeding risk for people with Atrial Fibrillation on anticoagulation with the ORBIT score, the tool NICE NG196 recommends.

Clinically reviewed by Aisha Malik, Clinical Director (GPhC 2205843), on .

ORBIT score0 of 7Low risk: 2.4 major bleeds per 100 patient-years

NICE NG196 recommends the ORBIT score for bleeding risk, alongside CHA₂DS₂-VASc. Use it to find risk factors you can change.

For health professionals. It supports clinical judgement and doesn’t replace it. Nothing you type leaves your browser.

How it’s worked out

Older age (75 or over) 1, reduced haemoglobin, haematocrit or a history of anaemia 2, bleeding history 2, insufficient kidney function (eGFR under 60) 1, treatment with an antiplatelet 1.

Scores run from 0 to 7.

What the result means

  • 0 to 2: low risk, 2.4 major bleeds per 100 patient-years.
  • 3: medium risk, 4.7 major bleeds per 100 patient-years.
  • 4 or more: high risk, 8.1 major bleeds per 100 patient-years.

Questions people ask

Why ORBIT rather than HAS-BLED?

NICE NG196 recommends ORBIT for bleeding risk in Atrial Fibrillation. Its risk factors are all routinely available in the record.

What counts as reduced haemoglobin?

Under 13 g/dL (130 g/L) for men or 12 g/dL (120 g/L) for women, or a haematocrit under 40% for men or 36% for women.

Sources

Checked against these sources on 19 November 2026.

  1. O'Brien EC et al. The ORBIT bleeding score. European Heart Journal 2015;36:3258–64
  2. British Journal of General Practice 2022: the ORBIT score and its interpretation (table 1)
  3. NICE guideline NG196: atrial fibrillation, diagnosis and management

Remote clinical pharmacists, funded through ARRS.

Book a 30-minute call